Southeast Michigan Surgical Hospital, LLC

Southeast Michigan Surgical Hospital, LLC was paid $9.18M by Medicaid between Jan 2018 and Dec 2024, across 95 billing codes. Its largest line is G0483, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed — 41% of everything it billed.

Compared with peers

Next to other Psychiatric Hospital Unit providers in Michigan

Rank by total paid#2 of 7

Median peer was paid$308K

This provider vs. median30×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	2,329	$62K
2019	4,422	$365K
2020	13,781	$861K
2021	23,401	$1.44M
2022	37,571	$2.45M
2023	27,892	$2.10M
2024incomplete	40,108	$1.90M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	41%	29,254	19,395	$3.74M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	26%	57,078	48,696	$2.40M
64483		9.2%	2,351	2,214	$848K
64493		5.4%	1,414	1,329	$492K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	4.5%	4,956	4,670	$416K
62321		2.8%	1,368	1,303	$261K
20610		2.4%	2,449	2,272	$225K
G0260	Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography	2.0%	1,088	1,041	$182K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	1.9%	5,537	5,332	$175K
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	<1%	580	515	$87K
62323		<1%	398	377	$63K
95911		<1%	219	211	$45K

83 more codes

64635		<1%	61	$29K
Q3014	Telehealth originating site facility fee	<1%	1,781	$27K
64450		<1%	120	$22K
64721		<1%	26	$19K
72100		<1%	1,678	$16K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	206	$15K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	58	$12K
72141		<1%	133	$12K
95910		<1%	92	$12K
95816		<1%	68	$10K
20550		<1%	125	$8K
64490		<1%	25	$7K
80305		<1%	1,590	$6K
20526		<1%	74	$6K
72110		<1%	208	$4K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	58	$4K
73564		<1%	326	$3K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	16	$3K
22505		<1%	26	$3K
95117		<1%	313	$3K
72050		<1%	180	$3K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	47	$3K
73630		<1%	392	$2K
20600		<1%	29	$2K
64405		<1%	26	$2K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	104	$2K
95909		<1%	12	$2K
73030		<1%	111	$1K
72040		<1%	148	$1K
73610		<1%	83	$987.78
73502		<1%	115	$936.89
72070		<1%	59	$802.20
99443		<1%	38	$784.44
20605		<1%	12	$728.64
73130		<1%	55	$643.98
A4649	Surgical supply; miscellaneous	<1%	554	$630.00
72120		<1%	293	$612.63
64494		<1%	1,487	$572.11
73110		<1%	26	$359.88
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	91	$322.83
81002		<1%	198	$215.78
80047		<1%	203	$103.80
85027		<1%	176	$74.20
81025		<1%	539	$70.22
36415	Collection of venous blood by venipuncture	<1%	472	$45.72
64484		<1%	1,533	$32.59
96127		<1%	93	$20.39
J2704	Injection, propofol, 10 mg	0%	1,060	$0.00
J3010	Injection, fentanyl citrate, 0.1 mg	0%	1,933	$0.00
J1100	Injection, dexamethasone sodium phosphate, 1 mg	0%	2,992	$0.00
J1170	Injection, hydromorphone, up to 4 mg	0%	180	$0.00
J1885	Injection, ketorolac tromethamine, per 15 mg	0%	593	$0.00
95886		0%	600	$0.00
J1040	Injection, methylprednisolone acetate, 80 mg	0%	2,360	$0.00
J1010	Injection, methylprednisolone acetate, 1 mg	0%	1,267	$0.00
J1030	Injection, methylprednisolone acetate, 40 mg	0%	1,203	$0.00
J2795	Injection, ropivacaine hydrochloride, 1 mg	0%	1,197	$0.00
76377		0%	126	$0.00
C9290	Injection, bupivacaine liposome, 1 mg	0%	32	$0.00
J2250	Injection, midazolam hydrochloride, per 1 mg	0%	61	$0.00
99213	Doctor's office visit, returning patient (routine)	0%	15	$0.00
J3490	Unclassified drugs	0%	13	$0.00
99214	Doctor's office visit, returning patient (more involved)	0%	13	$0.00
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	0%	3,157	$0.00
J7030	Infusion, normal saline solution , 1000 cc	0%	2,458	$0.00
64495		0%	255	$0.00
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	0%	52	$0.00
77003		0%	224	$0.00
A9575	Injection, gadoterate meglumine, 0.1 ml	0%	118	$0.00
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	0%	3,162	$0.00
77002		0%	1,947	$0.00
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	0%	136	$0.00
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	0%	2,398	$0.00
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	0%	574	$0.00
72275		0%	408	$0.00
64491		0%	13	$0.00
93041		0%	70	$0.00
64636		0%	63	$0.00
C1821	Interspinous process distraction device (implantable)	0%	12	$0.00
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	0%	15	$0.00
A4216	Sterile water, saline and/or dextrose, diluent/flush, 10 ml	0%	19	$0.00
J1580	Injection, garamycin, gentamicin, up to 80 mg	0%	12	$0.00
99203	Doctor's office visit, new patient (routine)	0%	14	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialIJAZ, NADIR (DIRECTOR)

Same official

Other billing entities under IJAZ, NADIR

Full network →

Provider	Location	Paid
Southeast Michigan Surgical Hospital, LLC	Warren, MI	$153K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.